Rheumatology · Boise, ID
NPI
1790147866
Since 2016
Specialty
Rheumatology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
500 W Fort St, #111r
Boise, ID, 83702
Phone (208) 422-1314
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$558K
920 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Irvin Huang prescribed most often to Medicare patients was Prednisone, with 280 prescriptions and refills. In total Irvin Huang wrote 920 Medicare prescriptions that cost $558K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 280 | 409 | 82 | $2,503 |
| Methotrexate Methotrexate Sodium | 132 | 305 | 46 | $2,270 |
| Hydroxychloroquine Sulfate Generic | 74 | 206 | 30 | $2,168 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 53 | 58 | 13 | $51K |
| Colchicine Generic | 44 | 75 | 19 | $873 |
| Allopurinol Generic | 34 | 102 | 11 | $429 |
| Rasuvo Methotrexate/Pf | 30 | 61 | Under 11 | $24K |
| Enbrel Sureclick Etanercept | 28 | 28 | Under 11 | $136K |
| Leflunomide Generic | 28 | 63 | Under 11 | $723 |
| Sulfasalazine Generic | 22 | 41 | Under 11 | $725 |
| Mycophenolate Mofetil Generic | 21 | 48 | Under 11 | $2,258 |
| Actemra Actpen Tocilizumab | 17 | 17 | Under 11 | $46K |
| Tyenne Autoinjector Tocilizumab-Aazg | 16 | 16 | Under 11 | $31K |
| Pilocarpine Hcl Generic | 15 | 17 | Under 11 | $537 |
| Febuxostat Generic | 13 | 29 | Under 11 | $810 |
Brand drugs: 218 claims; generic drugs: 702 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Irvin Huang were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.